You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

PTAB Cases from Cipla Ltd. et al.

✉ Email this page to a colleague

« Back to Dashboard

Patent Trial and Appeal Board Cases for Petitioner: Cipla Ltd. et al.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
7,820,788	Cipla Ltd. et al.	⤷ Sign Up	2017-11-09	11-17-2017		Inter partes review	⤷ Sign Up	05-08-2018		⤷ Sign Up
7,923,536	Cipla Ltd. et al.	⤷ Sign Up	2017-11-09	11-17-2017		Inter partes review	⤷ Sign Up	05-08-2018		⤷ Sign Up
8,138,229	Cipla Ltd. et al.	⤷ Sign Up	2017-11-09	11-17-2017		Inter partes review	⤷ Sign Up	05-08-2018		⤷ Sign Up
>Patent	>Petitioner	>Status	>Filing Date	>Accorded Filing Date	>Patent Owner	>Trial Type	>Trial Number	>Decision Date	>Inventor	>Document Download

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.